vs
InfuSystem Holdings, Inc（INFU）与RBB Bancorp（RBB）财务数据对比。点击上方公司名可切换其他公司
InfuSystem Holdings, Inc的季度营收约是RBB Bancorp的1.1倍（$36.2M vs $32.3M），RBB Bancorp同比增速更快（12.6% vs 7.0%），RBB Bancorp自由现金流更多（$42.6M vs $7.0M），过去两年RBB Bancorp的营收复合增速更高（7.0% vs 6.4%）
InfuSystem Holdings, Inc.是总部位于美国的医疗服务及设备供应商，主打输液治疗解决方案，提供可编程输液泵、配套一次性医用耗材及专业临床支持服务，服务覆盖北美地区的肿瘤诊所、家庭医疗服务商及急症护理机构。
RBB银行控股公司是总部位于美国的金融控股集团，旗下核心主体为皇家商业银行，主要服务亚裔社群、中小微企业、不动产投资者及零售客户，提供商业信贷、储蓄存款、财富管理等多元金融服务，业务覆盖美国沿海核心都会区。
INFU vs RBB — 直观对比
营收规模更大
INFU
是对方的1.1倍
$32.3M
营收增速更快
RBB
高出5.5%
7.0%
自由现金流更多
RBB
多$35.6M
$7.0M
两年增速更快
RBB
近两年复合增速
6.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $36.2M | $32.3M |
| 净利润 | — | $10.2M |
| 毛利率 | 56.4% | — |
| 营业利润率 | 10.3% | 39.5% |
| 净利率 | — | 31.5% |
| 营收同比 | 7.0% | 12.6% |
| 净利润同比 | — | 132.1% |
| 每股收益（稀释后） | $0.09 | $0.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INFURBB
| Q4 25 | $36.2M | $32.3M | ||
| Q3 25 | $36.5M | $32.6M | ||
| Q2 25 | $36.0M | $35.8M | ||
| Q1 25 | $34.7M | $28.5M | ||
| Q4 24 | $33.8M | $28.7M | ||
| Q3 24 | $35.3M | $30.3M | ||
| Q2 24 | $33.7M | $27.5M | ||
| Q1 24 | $32.0M | $28.2M |
净利润INFURBB
| Q4 25 | — | $10.2M | ||
| Q3 25 | $2.3M | $10.1M | ||
| Q2 25 | $2.6M | $9.3M | ||
| Q1 25 | $-267.0K | $2.3M | ||
| Q4 24 | — | $4.4M | ||
| Q3 24 | $1.8M | $7.0M | ||
| Q2 24 | $717.0K | $7.2M | ||
| Q1 24 | $-1.1M | $8.0M |
毛利率INFURBB
| Q4 25 | 56.4% | — | ||
| Q3 25 | 57.1% | — | ||
| Q2 25 | 55.2% | — | ||
| Q1 25 | 55.2% | — | ||
| Q4 24 | 53.8% | — | ||
| Q3 24 | 53.9% | — | ||
| Q2 24 | 49.5% | — | ||
| Q1 24 | 51.5% | — |
营业利润率INFURBB
| Q4 25 | 10.3% | 39.5% | ||
| Q3 25 | 10.4% | 40.7% | ||
| Q2 25 | 10.5% | 36.1% | ||
| Q1 25 | 1.8% | 11.2% | ||
| Q4 24 | 7.7% | 17.6% | ||
| Q3 24 | 9.2% | 31.6% | ||
| Q2 24 | 5.5% | 35.6% | ||
| Q1 24 | -2.6% | 39.9% |
净利率INFURBB
| Q4 25 | — | 31.5% | ||
| Q3 25 | 6.2% | 31.2% | ||
| Q2 25 | 7.2% | 26.1% | ||
| Q1 25 | -0.8% | 8.0% | ||
| Q4 24 | — | 15.3% | ||
| Q3 24 | 5.1% | 23.1% | ||
| Q2 24 | 2.1% | 26.4% | ||
| Q1 24 | -3.5% | 28.4% |
每股收益（稀释后）INFURBB
| Q4 25 | $0.09 | $0.59 | ||
| Q3 25 | $0.11 | $0.59 | ||
| Q2 25 | $0.12 | $0.52 | ||
| Q1 25 | $-0.01 | $0.13 | ||
| Q4 24 | $0.05 | $0.26 | ||
| Q3 24 | $0.08 | $0.39 | ||
| Q2 24 | $0.03 | $0.39 | ||
| Q1 24 | $-0.05 | $0.43 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.2M | $212.3M |
| 总债务越低越好 | $19.6M | $119.9M |
| 股东权益账面价值 | $57.3M | $523.4M |
| 总资产 | $100.6M | $4.2B |
| 负债/权益比越低杠杆越低 | 0.34× | 0.23× |
8季度趋势，按日历期对齐
现金及短期投资INFURBB
| Q4 25 | $3.2M | $212.3M | ||
| Q3 25 | $955.0K | $234.9M | ||
| Q2 25 | $720.0K | $191.9M | ||
| Q1 25 | $1.5M | $238.8M | ||
| Q4 24 | $527.0K | $257.7M | ||
| Q3 24 | $380.0K | $349.4M | ||
| Q2 24 | $146.0K | $252.8M | ||
| Q1 24 | $822.0K | — |
总债务INFURBB
| Q4 25 | $19.6M | $119.9M | ||
| Q3 25 | $20.9M | $119.8M | ||
| Q2 25 | $26.3M | $119.7M | ||
| Q1 25 | $28.7M | $119.6M | ||
| Q4 24 | $23.9M | $119.5M | ||
| Q3 24 | $28.0M | $119.4M | ||
| Q2 24 | $34.2M | $119.3M | ||
| Q1 24 | $29.9M | $119.2M |
股东权益INFURBB
| Q4 25 | $57.3M | $523.4M | ||
| Q3 25 | $55.5M | $514.3M | ||
| Q2 25 | $54.5M | $517.7M | ||
| Q1 25 | $55.1M | $510.3M | ||
| Q4 24 | $57.5M | $507.9M | ||
| Q3 24 | $55.5M | $509.7M | ||
| Q2 24 | $53.5M | $511.3M | ||
| Q1 24 | $52.3M | $514.0M |
总资产INFURBB
| Q4 25 | $100.6M | $4.2B | ||
| Q3 25 | $98.9M | $4.2B | ||
| Q2 25 | $100.8M | $4.1B | ||
| Q1 25 | $104.3M | $4.0B | ||
| Q4 24 | $103.6M | $4.0B | ||
| Q3 24 | $105.3M | $4.0B | ||
| Q2 24 | $108.5M | $3.9B | ||
| Q1 24 | $104.8M | $3.9B |
负债/权益比INFURBB
| Q4 25 | 0.34× | 0.23× | ||
| Q3 25 | 0.38× | 0.23× | ||
| Q2 25 | 0.48× | 0.23× | ||
| Q1 25 | 0.52× | 0.23× | ||
| Q4 24 | 0.41× | 0.24× | ||
| Q3 24 | 0.50× | 0.23× | ||
| Q2 24 | 0.64× | 0.23× | ||
| Q1 24 | 0.57× | 0.23× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $7.1M | $43.4M |
| 自由现金流经营现金流 - 资本支出 | $7.0M | $42.6M |
| 自由现金流率自由现金流/营收 | 19.3% | 131.8% |
| 资本支出强度资本支出/营收 | 0.4% | 2.5% |
| 现金转化率经营现金流/净利润 | — | 4.26× |
| 过去12个月自由现金流最近4个季度 | $23.8M | $73.5M |
8季度趋势，按日历期对齐
经营现金流INFURBB
| Q4 25 | $7.1M | $43.4M | ||
| Q3 25 | $8.5M | $2.1M | ||
| Q2 25 | $7.0M | $21.7M | ||
| Q1 25 | $1.8M | $7.8M | ||
| Q4 24 | $7.9M | $58.5M | ||
| Q3 24 | $9.8M | $24.5M | ||
| Q2 24 | $2.3M | $11.7M | ||
| Q1 24 | $377.0K | $4.8M |
自由现金流INFURBB
| Q4 25 | $7.0M | $42.6M | ||
| Q3 25 | $8.4M | $1.8M | ||
| Q2 25 | $6.8M | $21.6M | ||
| Q1 25 | $1.6M | $7.6M | ||
| Q4 24 | $7.4M | $57.7M | ||
| Q3 24 | $9.8M | $24.2M | ||
| Q2 24 | $2.0M | $11.5M | ||
| Q1 24 | $195.0K | $4.7M |
自由现金流率INFURBB
| Q4 25 | 19.3% | 131.8% | ||
| Q3 25 | 23.1% | 5.4% | ||
| Q2 25 | 18.9% | 60.2% | ||
| Q1 25 | 4.7% | 26.7% | ||
| Q4 24 | 21.9% | 201.0% | ||
| Q3 24 | 27.7% | 80.0% | ||
| Q2 24 | 5.9% | 42.0% | ||
| Q1 24 | 0.6% | 16.6% |
资本支出强度INFURBB
| Q4 25 | 0.4% | 2.5% | ||
| Q3 25 | 0.2% | 1.1% | ||
| Q2 25 | 0.6% | 0.3% | ||
| Q1 25 | 0.4% | 0.6% | ||
| Q4 24 | 1.6% | 2.7% | ||
| Q3 24 | 0.1% | 0.8% | ||
| Q2 24 | 1.0% | 0.5% | ||
| Q1 24 | 0.6% | 0.5% |
现金转化率INFURBB
| Q4 25 | — | 4.26× | ||
| Q3 25 | 3.76× | 0.21× | ||
| Q2 25 | 2.70× | 2.32× | ||
| Q1 25 | — | 3.39× | ||
| Q4 24 | — | 13.34× | ||
| Q3 24 | 5.45× | 3.50× | ||
| Q2 24 | 3.22× | 1.61× | ||
| Q1 24 | — | 0.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INFU
| Patient Services | $20.0M | 55% |
| Device Solutions | $14.4M | 40% |
| Other | $1.9M | 5% |
RBB
暂无分部数据
